Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC smoking cessation therapy Medicaid coverage required in latest Senate tobacco bill.

This article was originally published in The Tan Sheet

Executive Summary

OTC SMOKING CESSATION THERAPIES MEDICAID REQUIRED COVERAGE included in the latest version of S 1415, the National Tobacco Policy and Youth Smoking Reduction Act, brought to the Senate floor May 18. Under the manager's amendment, the bill would amend section 1927(d) of the Public Health Service Act, which allows states to exclude OTCs from Medicaid coverage, so that states may exclude all OTC drugs "except agents, approved by the Food and Drug Administration, when used to promote smoking cessation." States also would be required to cover Rx smoking cessation products. The Senate was scheduled to resume consideration of the legislation when it returned from recess June 1.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088498

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel